Globus Medical PE Ratio 2010-2023 | GMED
Current and historical p/e ratio for Globus Medical (GMED) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Globus Medical PE ratio as of December 07, 2023 is 19.16.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Globus Medical PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2023-12-07 | 45.33 | 29.25 | |
| 2023-09-30 | 49.65 | $1.55 | 32.03 |
| 2023-06-30 | 59.54 | $2.01 | 29.62 |
| 2023-03-31 | 56.64 | $1.97 | 28.75 |
| 2022-12-31 | 74.27 | $1.86 | 39.93 |
| 2022-09-30 | 59.57 | $1.51 | 39.45 |
| 2022-06-30 | 56.14 | $1.49 | 37.68 |
| 2022-03-31 | 73.78 | $1.36 | 54.25 |
| 2021-12-31 | 72.20 | $1.43 | 50.49 |
| 2021-09-30 | 76.62 | $1.81 | 42.33 |
| 2021-06-30 | 77.53 | $1.80 | 43.07 |
| 2021-03-31 | 61.67 | $1.19 | 51.82 |
| 2020-12-31 | 65.22 | $1.00 | 65.22 |
| 2020-09-30 | 49.52 | $0.92 | 53.83 |
| 2020-06-30 | 47.71 | $0.86 | 55.48 |
| 2020-03-31 | 42.53 | $1.45 | 29.33 |
| 2019-12-31 | 58.88 | $1.53 | 38.48 |
| 2019-09-30 | 51.12 | $1.45 | 35.26 |
| 2019-06-30 | 42.30 | $1.42 | 29.79 |
| 2019-03-31 | 49.41 | $1.48 | 33.39 |
| 2018-12-31 | 43.28 | $1.54 | 28.10 |
| 2018-09-30 | 56.76 | $1.43 | 39.69 |
| 2018-06-30 | 50.46 | $1.34 | 37.66 |
| 2018-03-31 | 49.82 | $1.19 | 41.87 |
| 2017-12-31 | 41.10 | $1.10 | 37.36 |
| 2017-09-30 | 29.72 | $1.10 | 27.02 |
| 2017-06-30 | 33.15 | $1.11 | 29.86 |
| 2017-03-31 | 29.62 | $1.09 | 27.17 |
| 2016-12-31 | 24.81 | $1.08 | 22.97 |
| 2016-09-30 | 22.57 | $1.22 | 18.50 |
| 2016-06-30 | 23.83 | $1.23 | 19.37 |
| 2016-03-31 | 23.75 | $1.21 | 19.63 |
| 2015-12-31 | 27.82 | $1.21 | 22.99 |
| 2015-09-30 | 20.66 | $1.06 | 19.49 |
| 2015-06-30 | 25.67 | $1.00 | 25.67 |
| 2014-12-31 | 23.77 | $0.97 | 24.51 |
| 2014-09-30 | 19.67 | $0.90 | 21.86 |
| 2014-06-30 | 23.92 | $0.92 | 26.00 |
| 2014-03-31 | 26.59 | $0.92 | 28.90 |
| 2013-12-31 | 20.18 | $0.78 | 25.87 |
| 2015-03-31 | 25.24 | $0.77 | 32.78 |
| 2013-09-30 | 17.46 | $0.73 | 23.92 |
| 2013-06-30 | 16.86 | $0.69 | 24.43 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $6.126B | $0.759B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $190.795B | 23.22 |
| Intuitive Surgical (ISRG) | United States | $109.234B | 73.00 |
| DexCom (DXCM) | United States | $45.569B | 87.36 |
| IDEXX Laboratories (IDXX) | United States | $43.316B | 53.22 |
| Edwards Lifesciences (EW) | United States | $42.146B | 27.68 |
| IQVIA Holdings (IQV) | United States | $39.345B | 23.49 |
| Alcon (ALC) | Switzerland | $35.469B | 29.12 |
| STERIS (STE) | Ireland | $19.690B | 23.87 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.929B | 0.00 |
| Waters (WAT) | United States | $17.118B | 24.19 |
| Hologic (HOLX) | United States | $16.587B | 17.50 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.731B | 14.81 |
| Sysmex ADR (SSMXY) | Japan | $11.457B | 33.72 |
| Teleflex (TFX) | United States | $10.784B | 16.80 |
| Penumbra (PEN) | United States | $8.565B | 148.93 |
| ShockWave Medical (SWAV) | United States | $6.366B | 26.87 |
| Abcam (ABCM) | United Kingdom | $5.500B | 0.00 |
| Masimo (MASI) | United States | $5.475B | 30.12 |
| Inari Medical (NARI) | United States | $3.517B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $3.200B | 12.99 |
| Elekta AB (EKTAY) | Sweden | $3.057B | 23.44 |
| Glaukos (GKOS) | United States | $3.039B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.883B | 19.70 |
| TransMedics (TMDX) | United States | $2.414B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.400B | 16.20 |
| Pacific Biosciences Of California (PACB) | United States | $2.273B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.190B | 18.25 |
| PROCEPT BioRobotics (PRCT) | United States | $1.950B | 0.00 |
| Veracyte (VCYT) | United States | $1.876B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.706B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.450B | 0.00 |
| OPKO Health (OPK) | United States | $1.237B | 0.00 |
| RxSight (RXST) | United States | $1.204B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.970B | 14.82 |
| Paragon 28 (FNA) | United States | $0.912B | 0.00 |
| Artivion (AORT) | United States | $0.731B | 89.15 |
| SiBone (SIBN) | United States | $0.721B | 0.00 |
| Nevro (NVRO) | United States | $0.685B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.684B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.550B | 0.00 |
| IRadimed (IRMD) | United States | $0.529B | 32.55 |
| Mesa Laboratories (MLAB) | United States | $0.512B | 15.95 |
| Pulse Biosciences (PLSE) | United States | $0.496B | 0.00 |
| CVRx (CVRX) | United States | $0.469B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.398B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.375B | 0.00 |
| AxoGen (AXGN) | United States | $0.314B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.307B | 11.26 |
| Semler Scientific (SMLR) | United States | $0.292B | 17.02 |
| AngioDynamics (ANGO) | United States | $0.270B | 0.00 |
| Accuray (ARAY) | United States | $0.258B | 0.00 |
| 908 Devices (MASS) | United States | $0.239B | 0.00 |
| NeuroPace (NPCE) | United States | $0.216B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.199B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.162B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.137B | 0.00 |
| Inogen (INGN) | United States | $0.116B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.110B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.092B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.092B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.079B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.066B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.065B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.063B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.061B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.061B | 0.00 |
| InspireMD (NSPR) | Israel | $0.055B | 0.00 |
| Neuronetics (STIM) | United States | $0.055B | 0.00 |
| Eargo (EAR) | United States | $0.054B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.049B | 0.00 |
| DarioHealth (DRIO) | United States | $0.049B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.046B | 0.00 |
| Spectral AI (MDAI) | United States | $0.046B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.040B | 0.00 |
| Envoy Medical (COCH) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.038B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.036B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.035B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.028B | 0.00 |
| PAVmed (PAVM) | United States | $0.026B | 0.00 |
| LENSAR (LNSR) | United States | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| PetVivo Holdings (PETV) | United States | $0.015B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.013B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.012B | 0.00 |
| Sientra (SIEN) | United States | $0.009B | 0.00 |
| Venus Concept (VERO) | Canada | $0.008B | 0.00 |
| Nemaura Medical (NMRD) | United States | $0.006B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Avinger (AVGR) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
